InspireMD Files 8-K on Officer/Director Changes & Compensation
Ticker: NSPR · Form: 8-K · Filed: Oct 1, 2024 · CIK: 1433607
| Field | Detail |
|---|---|
| Company | Inspiremd, INC. (NSPR) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation, corporate-governance
TL;DR
InspireMD 8-K: Leadership shakeup and new pay deals announced.
AI Summary
InspireMD, Inc. filed an 8-K on October 1, 2024, reporting on events as of September 30, 2024. The filing primarily concerns the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and executive compensation structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with compensation adjustments, can signal internal shifts that may affect future performance.
Key Players & Entities
- InspireMD, Inc. (company) — Registrant
- September 30, 2024 (date) — Date of earliest event reported
- October 1, 2024 (date) — Filing date
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided text.
Are there any details about the new compensatory arrangements for the officers mentioned?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the specific details of these arrangements are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' being included in this 8-K?
Including financial statements and exhibits in an 8-K typically means the company is disclosing material financial information or supporting documents alongside the other reported events.
When was InspireMD, Inc. incorporated and in which state?
InspireMD, Inc. was incorporated in Delaware.
What was InspireMD, Inc.'s former company name?
InspireMD, Inc.'s former company name was Saguaro Resources, Inc., with a date of name change on April 28, 2008.
Filing Stats: 713 words · 3 min read · ~2 pages · Grade level 12.9 · Accepted 2024-10-01 16:05:36
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share NSPR The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex10-1.htm (EX-10.1) — 143KB
- ex10-2.htm (EX-10.2) — 65KB
- ex10-3.htm (EX-10.3) — 74KB
- ex10-4.htm (EX-10.4) — 47KB
- 0001493152-24-039017.txt ( ) — 605KB
- nspr-20240930.xsd (EX-101.SCH) — 3KB
- nspr-20240930_lab.xml (EX-101.LAB) — 33KB
- nspr-20240930_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: October 1, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer